Home

Press Releases

12345678910
Exploring the Leading Paint Protection Film Manufacturing Base: The Technological Revolution in a 470,000m² Factory
Located in the 470,000m² modern industrial park of the Shantou Free Trade Zone, Blocks B03, 04, and 06, German magnetron sputtering equipment and Japanese precision coating lines operate in cleanroom environments rated to Class 100.——This is the Wanshun RIEOS® global production base.
Via AB Newswire · November 3, 2025
Hilipert Neck Massager Reviews: Don't Waste Your Money Uninformed?
NEW YORK, NY / ACCESS Newswire / November 3, 2025 / Neck pain and stiffness affect millions of people globally, often making daily life more uncomfortable than it should be. Whether it's long hours spent at a desk, stress-related tension, or muscle strain from physical activity, neck discomfort can interfere with simple routines like sleeping, reading, or driving.
Via ACCESS Newswire · November 3, 2025
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia vera, including the Phase 3 VERIFY study, will be the focus of four presentations at the 67th Annual American Society of Hematology (ASH) Annual Meeting being held in Orlando, Florida, from December 6-9, 2025.
Via ACCESS Newswire · November 3, 2025
Virtus Total Return Fund Inc. Announces Commencement of Tender Offer
Virtus Total Return Fund Inc. (NYSE: ZTR) (the “Fund”) today announced the commencement of a tender offer (“Tender Offer”) that will begin on November 3, 2025, and expire at 5 p.m. (Eastern) on December 3, 2025 (the “Expiration Date”), which will also be the pricing date, unless the Tender Offer is extended. The Tender Offer was previously announced as a conditional tender offer subject to certain factors that have been determined to have been met.
By Virtus Total Return Fund Inc. · Via Business Wire · November 3, 2025
Viant to Participate in Upcoming Investor Conferences
Viant Technology Inc. (Nasdaq: DSP), a leader in CTV and AI-powered programmatic advertising, today announced that members of its management team are scheduled to participate in upcoming investor conferences.
By Viant Technology Inc. · Via Business Wire · November 3, 2025
National Storage Affiliates Trust Announces Preferred Equity Investment in Newly Formed Joint Venture
National Storage Affiliates Trust (“NSA” or the “Company”) (NYSE: NSA) today announced the Company has entered into a new joint venture with an affiliate of Investment Real Estate Management, LLC (“IRE”), one of NSA’s former participating regional operators (“PROs”), which manages self storage properties under the “Moove In” brand.
By National Storage Affiliates Trust · Via Business Wire · November 3, 2025
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com.
By Hims & Hers · Via Business Wire · November 3, 2025
TrueBlue Reports Third Quarter 2025 Results
TrueBlue (NYSE:TBI) today announced its third quarter results for 2025.
By TrueBlue · Via Business Wire · November 3, 2025
REPAY to Attend Upcoming Investor Conferences
Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”), a leading provider of integrated payment processing solutions, today announced that the Company will be attending the following upcoming investor conferences:
By Repay Holdings Corporation · Via Business Wire · November 3, 2025
Ichor Holdings, Ltd. Announces Third Quarter 2025 Financial Results
Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment, today announced third quarter 2025 financial results.
By Ichor Holdings, Ltd. · Via Business Wire · November 3, 2025
Paymentus Reports Third Quarter 2025 Financial Results
Paymentus Holdings, Inc. (“Paymentus”) (NYSE: PAY), a leading provider of cloud-based bill payment technology and solutions, today announced its unaudited financial results for the quarter ended September 30, 2025.
By Paymentus · Via Business Wire · November 3, 2025
Air Lease Announces Third Quarter 2025 Results
Air Lease (NYSE: AL) announces financial results for the three and nine months ended September 30, 2025.
By Air Lease Corporation · Via Business Wire · November 3, 2025
Coterra Energy Reports Third-Quarter 2025 Results, Announces Quarterly Dividend, and Provides Fourth-Quarter and Full Year 2025 Guidance Update
Coterra Energy Inc. (NYSE: CTRA) (“Coterra” or the “Company”) today reported third-quarter 2025 financial and operating results and declared a quarterly dividend of $0.22 per share. Additionally, the Company provided fourth-quarter production and capital guidance and updated full-year 2025 guidance.
By Coterra Energy Inc. · Via Business Wire · November 3, 2025
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase 3 randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AMONDYS 45 (casimersen) and VYONDYS 53 (golodirsen) compared to placebo in 225 patients, ages 6-13 years old, with Duchenne muscular dystrophy (Duchenne) amenable to exon 45 or 53 skipping.
By Sarepta Therapeutics, Inc. · Via Business Wire · November 3, 2025
Myomo to Report Third Quarter 2025 Financial Results on November 10
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions.
By Myomo, Inc. · Via Business Wire · November 3, 2025
Ameresco Reports Third Quarter 2025 Financial Results
Ameresco, Inc. (NYSE:AMRC), a leading energy infrastructure solutions provider, today announced financial results for the third quarter ended September 30, 2025. The Company also furnished supplemental information in conjunction with this press release in a Current Report on Form 8-K. The supplemental information, which includes Non-GAAP financial measures, has been posted to the “Investors” section of the Company’s website at www.ameresco.com. Reconciliations of Non-GAAP measures to the appropriate GAAP measures are included herein. All financial result comparisons made are against the prior year period unless otherwise noted.
By Ameresco, Inc. · Via Business Wire · November 3, 2025
International Battery Metals Ltd. Announces Promotion of Don Bender to Vice President of Technology
International Battery Metals Ltd. (“IBAT”) (TSXV: IBAT) & (OTCQB: IBATF), an advanced technology provider of modular direct lithium extraction (DLE) systems, today announced the promotion of Don Bender to Vice President of Technology. Bender previously served as the Company’s Director of Engineering.
By International Battery Metals Ltd. · Via Business Wire · November 3, 2025
Palantir Reports Q3 2025 U.S. Comm Revenue Growth of 121% Y/Y and Revenue Growth of 63% Y/Y; Guides Q4 Revenue to 61% Y/Y and U.S. Comm Revenue to 121% Y/Y; Raises FY 2025 Revenue Guidance to 53% Y/Y, Crushing Consensus Expectations
Palantir Technologies Inc. (NASDAQ:PLTR) today announced financial results for the third quarter ended September 30, 2025.
By Palantir Technologies Inc. · Via Business Wire · November 3, 2025
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the third quarter ended September 30, 2025, and provided a business update.
By Nuvation Bio Inc. · Via Business Wire · November 3, 2025
PLAYSTUDIOS, Inc. Announces Third Quarter Results
PLAYSTUDIOS, Inc. (NASDAQ: MYPS) (“PLAYSTUDIOS” or the “Company”) today announced financial results for the third quarter ended September 30, 2025.
By PLAYSTUDIOS, Inc. · Via Business Wire · November 3, 2025
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences:
By Mirum Pharmaceuticals, Inc. · Via Business Wire · November 3, 2025
Savara Announces Participation in Upcoming Investor Healthcare Conferences
Savara Inc. (Nasdaq: SVRA) (the “Company”), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1x1 meetings and participate in fireside chats at two upcoming healthcare conferences.
By Savara Inc. · Via Business Wire · November 3, 2025
Magnachip Reports Results for Third Quarter 2025
Magnachip Semiconductor Corporation (NYSE: MX) (“Magnachip” or the “Company”) today announced financial results for the third quarter 2025.
Fastenal Names New Chief Financial Officer and Senior Executive Vice President
Fastenal Company (Nasdaq: FAST) (the 'Company' or 'Fastenal') has appointed Max Tunnicliff to the position of Chief Financial Officer and Senior Executive Vice President, effective November 10, 2025.
By Fastenal Company · Via Business Wire · November 3, 2025
Medifast Announces Third Quarter 2025 Financial Results
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025.
By Medifast · Via Business Wire · November 3, 2025
Addus HomeCare Announces Third Quarter 2025 Financial Results
Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025.
By Addus HomeCare Corporation · Via Business Wire · November 3, 2025
Infinity Natural Resources Announces Third Quarter 2025 Results Earnings Release and Conference Call Dates
Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) announced today that it will report 2025 third quarter financial and operating results after market close on Monday, November 10, 2025. Management will host a conference call the following day, Tuesday, November 11, 2025, at 10:00 a.m. ET to discuss the results.
By Infinity Natural Resources, Inc. · Via Business Wire · November 3, 2025
Asana to Announce Third Quarter Fiscal Year 2026 Financial Results on Tuesday, December 2, 2025
Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), a leading work management platform for human + AI collaboration, announced today that it will release financial results for the third quarter fiscal year 2026 on Tuesday, December 2, after the close of the U.S. markets.
By Asana, Inc. · Via Business Wire · November 3, 2025
Exact Sciences Announces Third Quarter 2025 Results
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $851 million for the third quarter ended September 30, 2025, compared to $709 million for the same period of 2024.
By Exact Sciences Corp. · Via Business Wire · November 3, 2025
Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
CINCINNATI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Mobile Infrastructure Corporation (NASDAQ: BEEP), the nation’s only publicly traded owner of parking infrastructure, will issue its third quarter 2025 earnings release after the U.S. market closes on Monday, November 10, 2025.
By Mobile Infrastructure · Via GlobeNewswire · November 3, 2025
ThredUp Announces Third Quarter 2025 Results
All results reported are for continuing operations, unless otherwise noted.
By ThredUp Inc. · Via GlobeNewswire · November 3, 2025
Every BODY Belongs: Club Pilates Rolls Out National Campaign Starring Real Members
Club Pilates – the largest Pilates brand globally– unveiled today its first national brand campaign, “Every Body Club Pilates,” a bold invitation to join the movement that’s always welcomed everyone: “Pilates is for every BODY.” The fully integrated campaign is now live nationwide, aiming to reframe Pilates for today’s culture by centering strength and accessibility for all ages, body types, and experience levels.
By Xponential (Consumer) · Via Business Wire · November 3, 2025
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
By Nyxoah · Via GlobeNewswire · November 3, 2025
James River Announces Third Quarter 2025 Results
PEMBROKE, Bermuda, Nov. 03, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) reported a net loss from continuing operations available to common shareholders of $0.4 million, or ($0.01) per diluted share, compared to a net loss from continuing operations available to common shareholders of ($40.7 million), or ($1.07) per diluted share, for the same 2024 period. Adjusted net operating income1 for the third quarter of 2025 was $17.4 million or $0.32 per diluted share, compared to ($28.2 million), or ($0.74) per diluted share, for the same 2024 period.
By James River Group Holdings, Ltd. · Via GlobeNewswire · November 3, 2025
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
Highlights
By Myriad Genetics, Inc. · Via GlobeNewswire · November 3, 2025
TELA Bio Appoints William Plovanic to Board of Directors
MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (“Bill”) Plovanic, CFA, to its Board of Directors.
By TELA Bio, Inc. · Via GlobeNewswire · November 3, 2025
Glucotrack, Inc. Encourages Shareholders to Vote
The Special Meeting of Shareholders reconvenes on November 7, 2025
By Glucotrack, Inc. · Via GlobeNewswire · November 3, 2025
ZoomInfo Announces Third Quarter 2025 Financial Results
ZoomInfo (NASDAQ: GTM), the Go-To-Market Intelligence Platform, today announced its financial results for the third quarter ended September 30, 2025.
By ZoomInfo · Via Business Wire · November 3, 2025
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis
By Abivax · Via GlobeNewswire · November 3, 2025
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Cambridge, Massachusetts, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, and members of senior management will be participating in a fireside chat and investor one-on-one meetings at the Guggenheim 2nd Annual Healthcare Innovation Conference on Monday, November 10th, 2025 in Boston, MA.
By ProMIS Neurosciences Inc. · Via GlobeNewswire · November 3, 2025
Flux Power to Host Fiscal First Quarter 2026 Financial Results Conference Call on November 13, 2025
VISTA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, will report its fiscal first quarter 2026 results on Thursday, November 13, 2025, after market close. Krishna Vanka, Chief Executive Officer, and Kevin Royal, Chief Financial Officer, will host a conference call at 4:30 p.m. ET to discuss the Company’s financial results, followed by a question-and-answer session.
By Flux Power · Via GlobeNewswire · November 3, 2025
Pyxis Oncology to Participate in Upcoming Investor Conferences
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that management will participate in the following upcoming investor conferences in November 2025:
By Pyxis Oncology · Via GlobeNewswire · November 3, 2025
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis
Validation study data show AdvanceAD-Tx can identify patients with AD who have a ‘JAKi responder profile’ and a superior response to JAKi therapies compared to Th2-targeted therapies
By Castle Biosciences, Inc. · Via GlobeNewswire · November 3, 2025
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in November:
By Relay Therapeutics, Inc. · Via GlobeNewswire · November 3, 2025
Ormat Technologies Reports Third Quarter 2025 Financial Results
STRATEGIC PORTFOLIO EXPANSION AND STRONG PRODUCT SEGMENT PERFORMANCE DROVE REVENUE AND EARNINGS GROWTH
By Ormat Technologies, Inc. · Via GlobeNewswire · November 3, 2025
BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors
By The Beauty Health Company · Via GlobeNewswire · November 3, 2025
Lakeland Fire + Safety Declares Cash Dividend for Fourth Quarter 2026
HUNTSVILLE, Ala., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its Board of Directors declared a cash dividend for its fiscal fourth quarter of 2026 of $0.03 per share. The dividend will be paid on November 24, 2025, to stockholders of record as of November 17, 2025.
By Lakeland Industries, Inc. · Via GlobeNewswire · November 3, 2025
Regeneron Announces Investor Conference Presentations
TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:
By Regeneron Pharmaceuticals, Inc. · Via GlobeNewswire · November 3, 2025
InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri, MD, MBA as its Chief Medical Officer, effective November 3, 2025.
By InnovAge · Via GlobeNewswire · November 3, 2025
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
The virtual webcast will take place Wednesday, November 12, 2025, at 8 a.m. ET
By Artiva Biotherapeutics, Inc. · Via GlobeNewswire · November 3, 2025